Open Access Green as soon as Postprint is submitted to ZB.
Transcriptional control of leukemogenesis by the chromatin reader SGF29.
Blood 143, 697-712 (2023)
Aberrant expression of stem-cell-associated genes is a common feature in acute myeloid leukemia (AML) and is linked to leukemic self-renewal and therapy resistance. Using AF10-rearranged leukemia as a prototypical example of the recurrently activated "stemness" network in AML, we screened for chromatin regulators that sustain its expression. We deployed a CRISPR-Cas9 screen with a bespoke domain-focused library and identified several novel chromatin-modifying complexes as regulators of the TALE domain transcription factor MEIS1, a key leukemia stem cell (LSC)-associated gene. CRISPR droplet sequencing revealed that many of these MEIS1 regulators coordinately controlled the transcription of several AML oncogenes. In particular, we identified a novel role for the Tudor-domain containing chromatin reader protein SGF29 in the transcription of AML oncogenes. Furthermore, SGF29 deletion impaired leukemogenesis in models representative of multiple AML subtypes in multiple AML subtype models. Our studies reveal a novel role for SGF29 as a non-oncogenic dependency in AML and identify the SGF29 Tudor domain as an attractive target for drug discovery.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Bone-marrow-cells; Hox Genes; H3k79 Methylation; Leukemia; Expression; Hematopoiesis; Proteomics; Acetylation; Maintenance; Inhibition
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
Journal
Blood
Quellenangaben
Volume: 143,
Issue: 8,
Pages: 697-712
Publisher
American Society of Hematology
Publishing Place
2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
Grants
Department of Defense Horizon Award
V Foundation for Cancer Research
Emerging Scientist Award from the Children's Cancer Research Fund
Luke Tatsu Johnson Foundation
Rally Foundation for Childhood Cancer Research
National Cancer Institute
National Institutes of Health
V Foundation for Cancer Research
Emerging Scientist Award from the Children's Cancer Research Fund
Luke Tatsu Johnson Foundation
Rally Foundation for Childhood Cancer Research
National Cancer Institute
National Institutes of Health